Gotenba, Japan

Yuji Wakahara



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 53(Granted Patents)


Location History:

  • Shizuoka, JP (2005 - 2008)
  • Gotemba, JP (2012)
  • Gotenba, JP (2010 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yuji Wakahara: Innovator in Hematopoietic Tumor Treatments

Introduction

Yuji Wakahara is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of hematopoietic tumors. With a total of 6 patents to his name, Wakahara's work is paving the way for innovative therapeutic solutions.

Latest Patents

Wakahara's latest patents include a therapeutic agent for hematopoietic tumors, which involves an inducing or enhancing agent for the expression of the HM1.24 antigen in hematopoietic tumor cells. This agent comprises interferon α, interferon γ, or the IRF-2 protein as an active ingredient. Additionally, he has developed an antitumor agent that combines this enhancing agent with an antibody against HM1.24. Another notable patent is a method for treating myeloma that utilizes an expression enhancer for the HM1.24 antigen. This enhancer, which includes interferon-α or interferon-γ, is expected to activate the promoter of the gene encoding HM1.24 antigen, thereby enhancing its expression in myeloma cells.

Career Highlights

Wakahara is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has been instrumental in advancing research and development in hematological therapies. His innovative approaches have garnered attention in the medical community, contributing to the ongoing fight against cancer.

Collaborations

Wakahara has collaborated with notable colleagues such as Koh Sato and Naohiro Yabuta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.

Conclusion

Yuji Wakahara's contributions to the field of hematopoietic tumor treatments exemplify the impact of innovation in medicine. His patents and ongoing research continue to inspire advancements in therapeutic strategies for cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…